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Chemicals entrapped in erythrocytes by hypotonic hemolysis can be assessed for possible antiparasitic
activity both in vivo and in vitro, regardless of whether they are able to diffuse into erythrocytes readily.
Inositol hexaphosphate, a highly charged compound, produced a dramatic lowering of the percentage of cells
infected by Babesia microhi in vivo and both B. microti and Plasmodium fakciparum in vitro. Several possible
mechanisms for this observation are discussed.
To act directly on intracellular parasites during the intra-
cellular phase of their life cycle, drugs must first diffuse or be
transported into the cell. Many chemicals do not enter cells
readily, for example, polar or charged compounds which
cannot diffuse readily through hydrophobic membranes.
Direct assay of a chemical for antiparasitic activity is there-
fore complicated because its chemotherapeutic effects can-
not be readily differentiated from the properties that permit
it to gain entry into the host cell. Probably many chemicals
with antiparasitic properties exist which are unrecognized
because they do not readily enter host cells. If their anti-
parasitic properties were known, chemicals with the neces-
sary antiparasitic properties could, in some cases, be con-
verted into effective drugs by introduction of chemical
modifications to increase hydrophobicity or by synthesis of
analogs of compounds whose entry is mediated by specific
transport proteins. Or, if the mechanism by which a chemi-
cal acts were known, drugs which produce a similar effect on
the target but are more readily transported could be sought.
For these reasons, it would be useful to develop a system
for testing the intracellular antiparasitic properties of chem-
icals which are not able to enter cells readily. Chemicals or
drugs normally unable to be transported across erythrocyte
membranes can be entrapped in erythrocytes by hypotonic
lysis, followed by subsequent resealing of the plasma mem-
brane. Erythrocytes containing drugs loaded in this way
might be useful as circulating drug carriers or for delivery of
drugs to erythrophagocytic cells (reviewed by Ihler and
Tsang [9]). Certain chemicals loaded into erythrocytes can
produce substantial alterations in the properties of the eryth-
rocytes themselves. Because inositol hexaphosphate (IHP)
is a much stronger allosteric modifier of hemoglobin than
2,3-diphosphoglycerate (2), IHP-loaded erythrocytes release
oxygen more readily than do normal cells and therefore have
an oxygen dissociation curve which is shifted to higher Po2
values (reviewed by Nicolau et al. [13]). Avian erythrocytes,
but not mammalian erythrocytes, utilize inositol pentaphos-
phate as a modifier of hemoglobin affinity for oxygen,
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presumably as an adaptation to permit greater oxygen deliv-
ery to flight musculature. IHP-loaded erythrocytes are func-
tional in mammals, as demonstrated by the survival of
piglets after complete exchange transfusion, but significant
and potentially useful and important physiological changes
were found after infusion of IHP-containing erythrocytes,
including a marked reduction in coronary blood flow in
isolated rat heart (21) and increased arterial Po2 and en-
hanced 02 extraction with decreased cardiac output in
piglets (22, 23).
Drugs entrapped in erythrocytes might not have direct
access to erythrocyte parasites such as plasmodia or Barto-
nella bacilliformis, which enter by a process analogous to
endocytosis and are, at least initially, found in intracellular
vacuoles separated from the erythrocyte cytoplasm by a
membrane (reviewed by Moulder in reference 11). However,
the plasma membrane which initially encloses Babesia
microti in a vacuole disintegrates after invasion and is lost
(20), and so this organism was selected for the initial
experiments since it is more likely to be susceptible to poorly
transported chemicals introduced into the erythrocyte cyto-
plasm by hypotonic lysis.
Hypotonic lysis and resealing, if carried out with certain
precautions, may have little or no adverse effect on the
survival of the resealed cells in vivo. Although there is early
loss of some cells after reinfusion, the loss is generally less
than 20 to 40% and often is not much greater than that
observed for washed, unlysed cells. It has been shown in
humans (19) and animals (reviewed by Ihler [8]) that the cells
which survive the first 24 to 48 h in a carefully resealed
erythrocyte preparation can have a normal life span.
We developed a procedure for studying the effect of
entrapped drugs on hemotrophic parasites, either in vivo or
in vitro. The novel features of this procedure are introduc-
tion of drugs by hypotonic lysis and simultaneous entrap-
ment of fluorescent compounds in the erythrocytes, which
permits the drug-containing erythrocytes to be easily distin-
guished from the host erythrocytes, either while they are
circulating (24) or on slides. This, in turn, permits the
number of drug-containing erythrocytes infused to be a small
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TABLE 1. Infection by B. microti in vivoa
Mean ± SEM (range) % of:
Erythrocytes Total Fluorescent
infusion erythrocytes erythrocytes
infected infected
IHP-FITC-BSA 67 ± 9 (50-79) 10 ± 4 (6-19)
FITC-BSA 76 ± 8 (64-87) 60 ± 4 (39-79)
a A total of 10 mice were used for the IHP-FITC-BSA experiments, and 8
mice were used with cells containing only FITC-BSA.
fraction of the total erythrocytes, so that their presence
should not perturb the course of the infection. Erythrocytes
from BALB/c mice were loaded with a fluorescent molecule
(24), either fluorescein isothiocyanate-bovine serum albumin
(FITC-BSA) or calcein, by using a modification (7) of the
preswell lysis procedure (17). Erythrocytes in heparin were
washed three times with phosphate-buffered saline contain-
ing 1.4 mM glucose and 5 mM inosine and then hypotonically
swollen without lysis by resuspension twice in 0.6x buffer
after gentle centrifugation, and the packed cells were lysed
by addition of 0.5 volume of 8 mg of FITC-BSA (or 1 mM
calcein) per ml and, where desired, 5 mM IHP or 1.2 mM
ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tetra-
acetic acid (EGTA). After gentle mixing, the cells were
incubated at room temperature for 5 min, resealed by
addition of 1.54 M KCl (0.15 volume of the lysing solution),
and then incubated for 30 min at 37°C, and washed several
times. Generally a higher percentage of erythrocytes was
fluorescent when IHP was omitted than when it was present;
probably, this effect is due to the contribution of IHP to the
osmolarity of the solution. When injected into uninfected
mice, fluorescent resealed erythrocytes continued to circu-
late for several days. Twenty-four-hour survival was about
50% (43% for cells containing IHP and 61% for cells not
containing IHP), which is similar to that previously reported
for mice (4, 6, 7). An additional one-third to one-half of the
infused erythrocytes were lost during the next 24 h, with the
remaining cells surviving with a more extended half-life.
Long-term survival was not routinely determined in these
experiments, but after 3 days 18% of the fluorescent IHP-
containing cells were still circulating, as were 33% of the
fluorescent cells not containing IHP. It has been reported
that in mice the half-life of resealed erythrocytes which
survive the first day or two was 4 days for virus-containing
erythrocytes loaded by either dialysis or the preswell dilu-
tion procedure (7) and 7 days when loaded by dialysis (4).
Mice which had been injected intraperitoneally 6 days
previously with 106 B. microti and had about 60% para-
sitemia were injected in the tail veins or intraperitoneally
with 0.2 to 0.3 ml of resealed erythrocytes (15% hematocrit)
containing FITC-BSA (90 to 95% fluorescent cells) or FITC-
BSA plus IHP (65 to 70% fluorescent cells). For the latter
cells, IHP and FITC-BSA were entrapped simultaneously,
permitting IHP-containing cells to be identified by fluores-
cence of the entrapped FITC-BSA. The percentage of in-
fected cells overall was determined from Giemsa-stained
smears. The percentage of fluorescent (FITC-BSA-con-
taining) cells which were infected was determined by fluo-
rescence microscopy. Slides were stained with ethidium
bromide, a fluorescent DNA-intercalating agent, to render
the parasites fluorescent (16), and so both parasites and
erythrocytes could be directly visualized by fluorescence
microscopy. Within 18 to 20 h, B. microti had invaded the
fluorescent cells not containing IHP nearly to the same
extent as it had invaded the host cells (Table 1). Fluorescent
erythrocytes containing calcein or FITC-BSA plus EGTA
were parasitized to approximately the same extent as FITC-
BSA-containing cells, as were erythrocytes incubated with 5
mM IHP without entrapment before or after loading of
FITC-BSA.
A much lower percentage of IHP-containing fluorescent
cells than fluorescent control cells was parasitized. Only
10% of the fluorescent IHP-containing cells were parasit-
ized, as compared with 67% of the host cells. When the
resealed erythrocytes did not contain IHP, a mean of 60% of
the fluorescent erythrocytes contained parasites as deter-
mined by staining with ethidium bromide; 76% of the host
cells contained parasites. This result demonstrates that in
vivo IHP-loaded fluorescent erythrocytes were only one-
fifth as likely to contain B. microti as were similar cells not
containing IHP. Since the number of IHP-loaded cells is only
a small percentage of the total endogenous cells, reduced
parasitemia in IHP-containing cells does not reduce the
overall observed parasitemia, although if large numbers of
IHP-containing cells were infused the overall parasitemia
should presumably drop and possibly the mice could be
saved from eventual death by a partial or complete exchange
transfusion. We interpret the finding of reduced parasitemia
in IHP-containing cells to indicate either that B. microti fails
to enter IHP-containing cells effectively or, ifB. microti does
enter, that the parasite either degenerates so that its pres-
ence cannot be detected by staining or that parasite-con-
taining erythrocytes are effectively removed from the circu-
lation.
The same system using hypotonic loading of chemicals
and fluorescent compounds developed for the in vivo exper-
iments can also be used in vitro, where in principle it might
be simpler to determine whether an antiparasitic drug af-
fected entry or subsequent development. We were unsuc-
cessful in setting up a continuous cultivation system for B.
microti by using mouse cells because the mouse erythro-
cytes lysed after incubation (however, a continuous culture
system has been reported for B. bovis [10]). We were able to
achieve in vitro infection of human erythrocytes added to a
mouse erythrocyte inoculum, although B. microti develop-
ment was arrested in the human erythrocytes at an early
stage and so the cultures were not self-sustaining. Although
this disadvantage eliminated the possibility of determining
whether IHP had an effect on B. microti development, the
results suggest that IHP has an effect on the entry process
and that IHP loaded in human erythrocytes could have an
antiparasitic effect.
B. microti was cultured in vitro by a modification of the
procedure of Palmer et al. (14), in 60% medium 199 with
Earle modified salts (Irvine Scientific), 40% human plasma, 2
mM glutamine, 4 mM N-tris(hydroxymethyl)methyl-2-ami-
noethanesulfonic acid, 10 mM inositol, and 0.03 mM gluta-
thion, starting with 20 ,d of packed erythrocytes per ml from
mice with 50 to 60% infected erythrocytes which were mixed
with 60 ,ul of packed, washed human erythrocytes or packed
resealed fluorescent human cells, either containing or not
containing IHP, per ml. Penicillin-streptomycin-Fungizone
(GIBCO Laboratories) was added to the final packed-eryth-
rocyte suspensions. Samples of 200 IlI were pipetted into
wells of a 96-well culture plate and incubated at 37°C in a
candle jar. The cells were allowed to settle, and every 24 h
150 ,lI of supernatant was replaced with 150 ,ul of fresh
medium without disturbing the cells. In three experiments
using washed human erythrocytes added to the infected
mouse erythrocytes, initially 17 to 25% of the erythrocytes
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TABLE 2. Infection by P. falciparum in vitro"
% Erythrocytes % Fluorescent
Erythrocyte infected erythrocytes infected
treatment
I N H I N H
IHP-FITC-BSA 0.66 0.53 2.87 0.0jb 0.00 0.00
EGTA-FITC-BSA 1.88 1.36 - 0.55 0.60
FITC-BSA 1.56 1.54 3.81 0.95 0.80 0.56
Resealing 1.43 1.20 3.28 - -
Washing 1.10 0.98 4.62
a Human erythrocytes, loaded with FITC-BSA with or without IHP or
EGTA, were sent by Air Express to the Centers for Disease Control identified
only with codes. In various experiments, three strains of P. falciparum were
used: Indochina 1 (I), Nigeria 3-CDC (N), and Honduras 1/CDC (clone b3)
(H). Initially, FITC-BSA erythrocytes contained 82% (I and N) or 70% (H)
fluorescent cells, and IHP-FITC-BSA cells contained 65% (I and N) or 40%o
(H) fluorescent cells. Slides were examined at 24, 48, and 96 h of culture; data
are given for the 96-h Indochina 1 and Nigeria (I and N) cultures and for the
48-h Honduras (H) cultures. The percentages of fluorescent cells in the 96-h
FITC-BSA culture were 20%o (I and N) and 3.7% in the 96-h IHP-FITC-BSA
culture. The percentage of fluorescent cells in the 48-h (H) culture was 30%o for
both FITC-BSA and IHP-FITC-BSA cells. -, Not done.
b No P. falciparum organisms were seen in IHP-containing cells in any
experiment, despite routine scanning of more than 10-fold more fluorescent
erythrocytes (n = 20,000) than erythrocytes not containing IHP (n = 2,000).
overall were infected, but this dropped rapidly to 3.9 to 7.6%
in 24 h and to 1.2 to 2.2% at 48 h because of lysis of the
mouse cells. On the basis of cell size, by 48 h most of the
cells remaining appeared to be human erythrocytes.
In a series of three experiments, the percentages of cells
infected with parasites at 48 h were 1.8 ± 0.3% (range, 1.35
to 2.15%) for cultures to which washed erythrocytes had
been added, 2.2 + 0.5% (range, 1.9 to 2.9%) for preparations
of resealed erythrocytes with a mean of54% fluorescent cells
containing FITC-BSA, and 1.6 ± 0.1% (range, 1.5 to 2.3%)
for resealed erythrocytes with a mean of 28% fluorescent
cells containing FITC-BSA and IHP. For cells resealed in
the absence of IHP, 1.3 ± 0.2% of the fluorescent cells
contained parasites, and for cells resealed in the presence of
IHP, 0.32 ± 0.15% of the fluorescent cells contained para-
sites. This indicates that in vitro IHP-containing resealed
fluorescent cells were invaded to about one-third of the level
of fluorescent cells resealed in the absence of IHP. The
results observed were similar whether the erythrocytes
contained FITC-BSA or calcein. These results are consistent
with those obtained in vivo and suggest that one inhibitory
action of IHP is to prevent entry of the parasite. Although
infrequent, human infections by B. microti are known and
there is unfortunately no good chemotherapeutic agent avail-
able. The demonstration that human cells containing IHP
display reduced parasitemia suggests some directions for
further research. It is possible that IHP-containing human
erythrocytes will be available in the future as a new blood
transfusion product (18).
It is possible to maintain continuous in vitro cultures of
Plasmodium falciparum with human erythrocytes, and the
effect of intracellular IHP on infection by P. falciparum in in
vitro cultures was determined. The results (Table 2) indicated
that IHP-loaded erythrocytes might be completely resistant to
invasion by P. falciparum. In fact, no P. falciparum organ-
isms were seen in IHP-containing erythrocytes in any exper-
iment, despite extensive scanning of the erythrocytes.
Addition of IHP to the medium in concentrations of 5 or
0.5, but not 0.05, mM proved markedly inhibitory in this in
vitro system (Table 3). myo-Inositol was not inhibitory at the
same concentration. The inhibitory activity was assessed by
the 48-h reinvasion test (12) using clone B3 of the Honduras
TABLE 3. Inhibitory effect of external IHP
Erythrocyte No. of cells' with:
treatment and 2 Nucleus >2 Nucleus
concn (mM) Rings Trophozoites schizonts schizonts
None (control) 152 20 10 22
IHP
5 0 2 1 2
0.5 0 2 0 1
0.05 128 16 10 28
0.005 166 19 10 30
myo-Inositol
5 98 19 8 14
0.5 159 26 7 18
0.05 139 18 9 18
0.005 157 20 8 21
" Values are means for two duplicate cultures, except for the control, which
had four duplicate cultures. Parasites were counted against 10,000 erythro-
cytes.
1/CDC strain. Cultures contained a 5% cell suspension with
about 0.2% infected cells and were incubated in duplicate at
37°C in a candle jar for 48 h. The effect of external IHP is
probably due to chelation of calcium in the external medium.
Wasserman et al. (26) have shown that addition of 1 mM
EGTA to the culture blocks the cell cycle by two mecha-
nisms, one of which prevents reinvasion of fresh erythro-
cytes. Similar observations were made by Vial et al. (25).
Thus, it is likely that external IHP, a very potent Ca2+
chelator, acts by a similar mechanism. The effect of en-
trapped IHP is unlikely to be due to lysis of some of the cells
and release of the IHP, since that hypothesis cannot explain
the results obtained in vivo. We had anticipated that calcium
chelators would have an antiparasitic effect, which was one
reason why IHP was included as a test chemical, but IHP
may not act through chelation of Ca2 , since entrapped
EGTA or calcein had no effect on the entry of B. microti.
Dluzewski et al. (5) have reported that EGTA introduced
into resealed ghosts has no effect on invasion by P. falcipa-
rum. Entrapped IHP (or EGTA or calcein) had no inhibitory
effect (data not shown) on the entry of another hemotrophic
parasite, Bartonella bacilliformis (3).
IHP is a powerful allosteric effector of the oxygen affinity
of hemoglobin, much more so than 2,3-diphosphoglycerate
or ATP. The sensitivity of these parasites to oxygen is well
known, as indicated, for example, by the requirement for
diminished oxygen concentrations in vitro and the protection
provided by erythrocytes containing hemoglobin (1, 15). It
seems possible that the allosteric effects of IHP on hemo-
globin is responsible for the antiparasitic effect of IHP.
We thank Gerald McLaughlin for coordinating the experiments
with the Centers for Disease Control.
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